M L 13 (Levothyroxine 200 mcg (0.2 mg))
Pill imprint M L 13 has been identified as Levothyroxine sodium 200 mcg (0.2 mg).
Levothyroxine is used in the treatment of underactive thyroid; hypothyroidism, after thyroid removal; hashimoto's disease; tsh suppression; myxedema coma (and more), and belongs to the drug class thyroid drugs. Studies show no risk during pregnancy. Levothyroxine 200 mcg (0.2 mg) is not subject to the Controlled Substances Act.
See also related documents.
Images for M L 13 (Levothyroxine 200 mcg (0.2 mg))
Levothyroxine sodium
- Imprint:
-
M
L 13 - Strength:
- 200 mcg (0.2 mg)
- Color:
- Pink
- Size:
- 9.00 mm
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Thyroid drugs
- Pregnancy Category:
- A - Studies show no risk
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC):
- 00378-1819
- Inactive Ingredients:
- butylated hydroxyanisole
silicon dioxide
crospovidone
magnesium stearate
mannitol
microcrystalline cellulose
povidone
sodium lauryl sulfate
sucrose
FD&C Red No. 40
More resources
Levothyroxine sodium is associated with the treatment of:
Search Again
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...
